These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 3290953

  • 1. Is loss of antidepressant effect during continuation therapy related to placebo effect?
    Harrison W, Stewart JW, McGrath PJ, Tricamo E, Quitkin FM.
    Psychopharmacol Bull; 1988; 24(1):9-13. PubMed ID: 3290953
    [No Abstract] [Full Text] [Related]

  • 2. Review of placebo-controlled trials with bupropion.
    Zung WW.
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):104-14. PubMed ID: 6406436
    [Abstract] [Full Text] [Related]

  • 3. The use of bupropion in hospitalized depressed patients.
    Merideth CH, Feighner JP.
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):85-7. PubMed ID: 6406471
    [Abstract] [Full Text] [Related]

  • 4. The mousetrap: managing the placebo effect in antidepressant trials.
    Lakoff A.
    Mol Interv; 2002 Apr; 2(2):72-6. PubMed ID: 14993352
    [No Abstract] [Full Text] [Related]

  • 5. Factors that influence the outcome of placebo-controlled antidepressant clinical trials.
    Niklson IA, Reimitz PE, Sennef C.
    Psychopharmacol Bull; 1997 Apr; 33(1):41-51. PubMed ID: 9133750
    [Abstract] [Full Text] [Related]

  • 6. Phenelzine for chronic depression: a study of continuation treatment.
    Harrison W, Rabkin J, Stewart JW, McGrath PJ, Tricamo E, Quitkin F.
    J Clin Psychiatry; 1986 Jul; 47(7):346-9. PubMed ID: 3522558
    [Abstract] [Full Text] [Related]

  • 7. Clinical pharmacology of bupropion and imipramine in elderly depressives.
    Branconnier RJ, Cole JO, Ghazvinian S, Spera KF, Oxenkrug GF, Bass JL.
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):130-3. PubMed ID: 6406441
    [Abstract] [Full Text] [Related]

  • 8. Clinical profile of the novel antidepressant bupropion.
    Stern WC, Harto-Truax N, Rogers J, Miller L.
    Adv Biochem Psychopharmacol; 1982 May; 32():21-34. PubMed ID: 6807060
    [No Abstract] [Full Text] [Related]

  • 9. A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression.
    Guy W, Wilson WH, Ban TA, King DL, Manov G, Fjetland OK.
    Psychopharmacol Bull; 1984 May; 20(1):73-8. PubMed ID: 6425916
    [No Abstract] [Full Text] [Related]

  • 10. A review of controlled studies of adinazolam mesylate in patients with major depressive disorder.
    Feighner JP.
    Psychopharmacol Bull; 1986 May; 22(1):186-91. PubMed ID: 3523576
    [No Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of bupropion in elderly patients: preliminary observations.
    Kane JM, Cole K, Sarantakos S, Howard A, Borenstein M.
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):134-6. PubMed ID: 6406442
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of the safety and efficacy of bupropion in depression.
    Halaris AE, Stern WC, Van Wyck Fleet J, Reno RM.
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):101-3. PubMed ID: 6406435
    [Abstract] [Full Text] [Related]

  • 13. Efficacy in long-term treatment of depression.
    Montgomery SA.
    J Clin Psychiatry; 1996 May; 57 Suppl 2():24-30. PubMed ID: 8626360
    [Abstract] [Full Text] [Related]

  • 14. Methylphenidate in mild depression: a double-blind controlled trial.
    Mattes JA.
    J Clin Psychiatry; 1985 Dec; 46(12):525-7. PubMed ID: 3905773
    [Abstract] [Full Text] [Related]

  • 15. SAMe versus placebo: a double blind comparison in major depressive disorders.
    Muscettola G, Galzenati M, Balbi A.
    Adv Biochem Psychopharmacol; 1982 Dec; 32():151-6. PubMed ID: 7046362
    [No Abstract] [Full Text] [Related]

  • 16. Antidepressant response and plasma concentrations of bupropion.
    Preskorn SH.
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):137-9. PubMed ID: 6406443
    [Abstract] [Full Text] [Related]

  • 17. [Placebo-controlled antidepressant drug trials. Considering the ethical implications].
    Deisenhammer EA, Hinterhuber H.
    Fortschr Neurol Psychiatr; 2003 May; 71(5):243-8. PubMed ID: 12740755
    [Abstract] [Full Text] [Related]

  • 18. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
    Dominguez RA, Goldstein BJ, Jacobson AF, Steinbook RM.
    J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
    [Abstract] [Full Text] [Related]

  • 19. Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials.
    Khan A, Brodhead AE, Kolts RL, Brown WA.
    J Psychiatr Res; 2005 Mar; 39(2):145-50. PubMed ID: 15589562
    [Abstract] [Full Text] [Related]

  • 20. A comparative study of bupropion and amitriptyline in depressed outpatients.
    Mendels J, Amin MM, Chouinard G, Cooper AJ, Miles JE, Remick RA, Saxena B, Secunda SK, Singh AN.
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):118-20. PubMed ID: 6406439
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.